Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Search Icon
Search Icon
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Research Type:

Sort 1 results by:

Filter Applied. Clear All

Latest Posts

June 10, 2026 EXCLUSIVE: Many Women Blindsided By Abortion Pill Complications, New Study Shows EXCLUSIVE: Many Women Blindsided By Abortion Pill Complications, New Study Shows June 10, 2026 New Study Finds Informed Consent Gaps for Abortion Drugs as Women Report Unexpected Pain, Bleeding New Study Finds Informed Consent Gaps for Abortion Drugs as Women Report Unexpected Pain, Bleeding June 9, 2026 Substance Use Disorder in Pregnant Women: State of the Problem, Treatment, and Recommendations for Improving Interventions Substance Use Disorder in Pregnant Women: State of the Problem, Treatment, and Recommendations for Improving Interventions
Reset All Filters
Federal Bioethics Commissions and Bias Against the Unborn
Fetal Tissue, Stem Cells & Bioethics

Federal Bioethics Commissions and Bias Against the Unborn

In August, the Trump administration’s new Human Fetal Tissue Research Ethics Advisory Board reviewed requests made to the National Institutes of Health (NIH) for federally funded fetal tissue research. The Board recommended denying most of these requests.

Maternal & Public Health

Medical and Social Risks Associated with Unmitigated Distribution of Mifepristone: A Primer

Chemical abortions, or “medication” abortions, have become a more prevalent method of abortion in recent years in the United States. In 2000, the Food and Drug Administration (FDA) approved the use of mifepristone, in conjunction with the drug misoprostol, as an abortion-inducing, two-drug process. By 2018, the Charlotte Lozier Institute estimates that 41% of U.S. abortions were chemically induced.

Update: COVID-19 Vaccine Candidates and Abortion-Derived Cell Lines
Maternal & Public Health

Update: COVID-19 Vaccine Candidates and Abortion-Derived Cell Lines

Accurate information about the development and production of COVID-19 vaccines is essential, especially because many proposed candidates use newer molecular technologies for production of a viral vaccine.  One concern regarding the ethical assessment of viral vaccine candidates is the potential use of abortion-derived cell lines in the development, production or testing of a vaccine.  This analysis utilizes data from the primary scientific literature when available, along with data from clinical trial documents, reputable vaccine tracking websites, and published commercial information.1  It is the hope that by providing accurate data, recipients can make well-informed decisions regarding vaccine choices.

Maternal & Public Health

Abortion Reporting: South Dakota (2019)

South Dakota’s provisional 2019 abortion report was published by the South Dakota Department of Health in June 2020, and the final report was released in September. The final report shows that chemical abortions in South Dakota remain low.

Abortion

New Abortion Trends in the United States: A First Look

Today Charlotte Lozier Institute (CLI), the research arm of the national pro-life group Susan B. Anthony List (SBA List), published a new report on emerging abortion trends in the United States. Ahead of the Centers for Disease Control and Prevention, as well as the Guttmacher Institute, CLI has the first analysis of trends revealed by the latest available state abortion reports from calendar year 2018

New Abortion Trends in the United States: A First Look
Maternal & Public Health

New Abortion Trends in the United States: A First Look

To allow for a preliminary view of the current state of abortion in the U.S., the Charlotte Lozier Institute (CLI) reviewed all available state reports for 2017 and 2018. As of July 2020, 38 states had released 2018 abortion statistics. CLI’s preliminary review of 2017 state abortion reporting, published in May 2019, suggested that the long-term decline in abortions in the United States may be slowing. This preliminary review of 2018 state data indicates that the decline may have been interrupted.

A Policy and Funding Evaluation Of Human Fetal Tissue Research
Life & the Law

A Policy and Funding Evaluation Of Human Fetal Tissue Research

Here we evaluate the actions and policy changes made by the Trump administration that have been taken since his term in office and analyze the current standing of federal funds used to support fetal tissue research.  First, we give a brief overview of how federal tax dollars are used to fund medical research in the U.S.

Maternal & Public Health

Abortion Reporting: North Dakota (2019)

North Dakota’s abortion report for 2019 was published in June 2020. There were 20 fewer abortions in 2019 than in 2018.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image